Retrospective study of FibroScan®, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection;Estudio retrospectivo de la capacidad de evaluación de fibrosis hepática del FibroScan®, APRI, FIB-4 y FORNS con referencia a la biopsia hepática de pacientes con hepatitis crónica C, mono y coinfectados con VIH

Gastroenterologia y Hepatologia

Volumn 33, Issue 6, 2010, Pages 425-432

  González Guilabert, Maria Isabel ^a   Mena Bernal, Carmen Hinojosa ^a   del Pozo González, Jorge ^b   del Pozo Pérez, Miguel Angel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Biomarkers; Coinfection; Fibroscan; HCV; HIV; Liver biopsy; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; BIOLOGICAL MARKER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APRI INDEX; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE MARKER; FEMALE; FIB 4 INDEX; FORNS INDEX; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GOLD STANDARD; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POLYMERASE CHAIN REACTION; PREDICTION; PREDICTIVE VALIDITY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; BIOPSY; BLOOD; COMPARATIVE STUDY; COMPLICATION; ELASTOGRAPHY; EVALUATION STUDY; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; THROMBOCYTE COUNT;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BIOPSY; CHOLESTEROL; ELASTICITY IMAGING TECHNIQUES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 77953960627     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2010.02.005     Document Type: Article

References (31)

1. Poynard T., Yuen M.F., Ratziu V., Lai C.L. Viral hepatitis C. Lancet 2003, 362:2095-2100.
2. Friedman SL. The consequences of liver disease: Hepatic Fibrosis. En: Schiff ER, Sorrell MF, Maddrey WC, editores. Schiff's diseases of the liver. 9th ed. Philadelphia, Lippincott Williams and Wilkins; 2002. p. 409-28.
3. Strader D.B., Wright T., Thomas D.L., Leonard B.S. Diagnosis, management and treatment of hepatitis C hepatology. Hepatology 2004, 39:1147-1171.
4. Soriano V., Puoti M., Sulkowski M.S., Mauss S., Cacoub P., Carqnel A., et al. Care of patients with hepatitis C and HIV co-infection. AIDS 2004, 18:1-12.
5. Bedossa P. Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C. Hepatology 1994, 20:15-20. The French METAVIR Cooperative Study Group.
6. Cadranel J.F., Rufat P., Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the group of epidemiology of the french association for the study of the liver (AFEF). Hepatology 2000, 32:477-481.
7. Castera L., Negre I., Samii K., Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 1999, 30:1529-1530.
8. Bedossa P., Dargére D., Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38:1449-1457.
9. Rousselet M.C., Michalack S., Dupre F., Croue A., Bedossa P., Saint-Andre J.P., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005, 41:257-264.
10. Poynard T., Imbert-Bismut F., Munteanu M., Messous D., Myers R., Thabut D., et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comparative Hepatology 2004, 3:8.
11. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
12. Sterling R.K., Lissen E., Clumek C.K., Sola R., Cassia-Correa M., Montaner J., et al. Development of a simple non-invasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006, 43:1317-1325.
13. Koda M., Matunaga Y., Kawakami M., Kishimoto Y., Suou T., Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007, 45:297-306.
14. Imber-Bismut F., Ratziu V., Pieroni L., Benhamou Y., Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001, 357:1069-1075.
15. Lok A.S.F., Ghany M.G., Goodman Z.D., Wright E.C., Everson G.T., Sterling R.K., et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort. Hepatology 2005, 42:282-292. HALT-C Trial Group.
16. Forns X., Ampurdanes S., Llovet J.M., Aponte J., Quinto L., Martínez-Bauer E., et al. Identification of hepatitis chronic C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002, 36:986-992.
17. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
18. Castera L., Forns X., Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008, 48:835-847.
19. Ziol M., Handra-Luca A., Kettaneth A., Christidis C., Mal F., Kazemi F., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005, 41:48-54.
20. Friedrich-Rust M., Ong M.F., Martens S., Sarrazin C., Bojunga J., Zeuzem S., et al. Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis. Gastroenterology 2008, 134:960-974.
21. Talwalkar J.A., Kurtz D.M., Schoenleber S.J., West C.P., Montori V.M. Ultrasound-Based Transient Elastography for the Detection of Hepatic Fibrosis: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2007, 5:1214-1220.
22. Foucher J., Castera L., Bernard P.H., Adhoute X., Laharie D., Bertet J., et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroen Hepat 2006, 18:411-412.
23. Arena U., Vizzuti F., Abraldes J.G., Corti G., Stasi C., Moscarella S., et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008, 57:1288-1293.
24. Marcellin P., Asselah T., Boyer N. Fibrosis and disease progression in Hepatitis C. Hepatology 2002, 36:47-56.
25. Portilla J., López-Burgos A., Saiz-De-La-Hoya-Zámacola P., Sánchez-Pavá J., Bedía-Collantes M., Faraco-Atienzar I., et al. Utilidad de 2 modelos bioquímicos predictivos del grado de fibrosis hepática en la población penitenciaria con hepatitis C. Gastroenterol Hepatol 2009, 32:387-394.
26. Tong M.J., El-Farra N.S., Reikes A.R., Co R.L. Clinical outcomes after transfusion-associated hepatitis C. The New England Journal of Medicine 1995, 332:1463-1466.
27. Lacobellis A., Mangia A., Leandro G., Clemente R., Festa V., Attino V., et al. External validation of biochemical indices for non invasive evaluation of liver fibrosis in HCV chronic hepatitis. J Gastroenterol 2005, 100:868-873.
28. Leroy V., Hilleret M.N., Sturm N., Trocme C., Renversez J.C., Faure P., et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 2007, 46:775-782.
29. Sebastiani G., Vario A., Guido M., Noventa F., Plebani M., Pistis R., et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006, 44:686-693.
30. Kelleher T.B., Afdhal N. Assessment of liver fibrosis in co-infected patients. Hepatology 2006, 44:126-131.
31. Ghany M.G., Strader D.B., Thomas D.L., Seef L.B. Diagnosis, management and treatment of hepatitis C: An update. Hepatology 2009, 49:1335-1374.